A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
- Automatic adverse drug reaction extraction from electronic health records
- Eight ways chemical pollutants harm the body
- Researchers find AI can predict new atrial fibrillation, stroke risk
- Research may offer another avenue to tackling sexually aggressive behavior
- Research identifies impact of teenage screen use